Tofacitinib treatment alters mucosal immunity and gut microbiota during experimental arthritis

類似資料

• Lack of protective effect of CCR3 blockade during experimental colitis may be related to CCR3 expression by colonic Tregs
  著者:: Maroua Ferhat, 等
  出版事項: (2021-06-01)
• Emerging role of IκBζ in inflammation: Emphasis on psoriasis
  著者:: Preeti Gautam, 等
  出版事項: (2022-10-01)
• Anti-Inflammatory Activity of Bryophytes Extracts in LPS-Stimulated RAW264.7 Murine Macrophages
  著者:: Raíssa Volpatto Marques, 等
  出版事項: (2022-03-01)
• Tofacitinib
  著者:: Nilgün Şentürk
  出版事項: (2022-04-01)
• Tofacitinib: Revisión
  著者:: Carlos Ríos Acosta, 等
  出版事項: (2016-12-01)